The MCI Group has released a new thought leadership paper that focuses on the impact and effects of increasing transparency on the medical industry’s support of healthcare professionals and healthcare organisations.

The new paper aims to illustrate the key areas and influences associated with transparency, highlighting a range of viewpoints from key opinion leaders and commentators from medical associations and companies, trade associations, the press and observers.

The report, co-authored by Simon Dufaur, Strategy Consultant for Healthcare at MCI Brussels, and Cerstin Steindorf, Global Account Director for Healthcare at MCI Geneva, is based on field research carried out from December 2014 to February 2016 (OR over a period of 15 months).

It seeks to provide an insight on a number of healthcare industry topics such as whether healthcare compliance regulations and disclosure requirements have a positive impact on how the industry is perceived by the general public, and whether ethical codes concerning industry interactions with healthcare professionals have a direct benefit on their efficacy and patient care.

The report also highlights the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code – an initiative to harmonise transparency and disclosure requirements across 33 countries in Europe – and the Open Payments System in the United States. The concluding analysis focuses on the effects of transparency, risk management, predictions and recommendations.

MCI’s latest white paper illustrates its commitment to help healthcare companies and associations better engage their targeted audiences by rethinking traditional approaches, driving innovation and creating new experiences to foster change, inspire and educate